Pd Complexes Antimalarial and Anticancer Agents
pension if not completely dissolved. Stock solutions were stored at
[2] H. Beraldo, D. Gambino, Mini-Rev. Med. Chem. 2004, 4, 31–
9.
3] D. S. Kalisnowski, D. R. Richardson, Pharmacol. Rev. 2005,
7, 547–583.
4] D. S. Kalinowski, D. R. Richardson, Chem. Res. Toxicol. 2007,
0, 715–720.
[5] J. S. Casas, M. S. García-Tasende, J. Sordo, Coord. Chem. Rev.
000, 209, 197–261.
6] M. A. Ali, S. E. Livingstone, Coord. Chem. Rev. 1974, 13, 101–
15.
3
–20 °C. Further dilutions were prepared on the day of the experi-
[
[
ment. Chloroquine (CQ) was used as the reference drug in all ex-
periments. Test samples were tested at one concentration (10 µg/
mL). CQ was tested at concentrations of 30, 15 and 7.5 ng/mL.
5
2
Anticancer Experiments
2
Cell Lines and Cell Proliferation Assays: The three oesophageal
cancer cell lines, WHCO1, WHCO5 and WHCO6, were derived
[
1
from biopsies of primary oesophageal squamous cell carcinomas
[7] M. J. M. Campbell, Coord. Chem. Rev. 1975, 15, 279–319.
[8] S. Padhye, G. B. Kauffman, Coord. Chem. Rev. 1985, 63, 127–
160.
52]
(
oesophageal cancer cells of South African origin)[ and kindly
provided by Professor Rob Veale (University of Witwatersrand,
South Africa). The CaSki and HeLa cervical cancer cell lines were
purchased from the American Type Culture Collection (Rockville,
[9] A. G. Quiroga, C. N. Ranninger, Coord. Chem. Rev. 2004, 248,
1
19–133.
[
10] S. N. Pandeya, J. R. Dimmock, Pharmazie 1993, 48, 659–666.
MD, USA) and the KYSE oesophageal squamous cell carcinoma
cell lines, previously established by Shimada and co-workers,[53]
[11] T. S. Lobana, R. Sharma, G. Bawa, S. Khanna, Coord. Chem.
Rev. 2009, 253, 977–1055.
were purchased from the German Resource Centre for Biological
Material (http://www.dsmz.de). IC50 determinations were carried
out using the MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltet-
razolium bromide] assay. Briefly, 3000 cells were seeded per well in
[
[
[
12] A. A. El-Asmy, O. A. El-Gammal, H. S. Saleh, Spectrochimica
Acta Part A: Mol. Biomol. Spec. 2008, 71, 39–44.
13] S. Halder, R. J. Butcher, S. Bhattacharya, Polyhedron 2007, 26,
2741–2748.
2
96-well plates. Cells were incubated at 37 °C under 5% CO (24 h),
14] R. M. El-Shazly, G. A. A. Al-Hazmi, S. E. Ghazy, M. S. El-
after which aqueous DMSO solutions of each compound (10 µL,
with a constant final concentration of DMSO: 0.2%) were plated
at various concentrations. After 48 h incubation, observations were
made, and MTT (10 µL) solution added to each well. After a fur-
ther 4 h incubation, solubilization solution (100 µL) was added to
each well, and plates were incubated overnight. Plates were read at
Shahawi, A. A. El-Asmy, J. Coord. Chem. 2006, 59, 845–849.
[15] S. Halder, S.-M. Peng, G.-H. Lee, T. Chatterjee, A. Mukherjee,
S. Dutta, U. Sanyal, S. Bhattacharya, New J. Chem. 2008, 32,
105–114.
[
[
[
16] T. Stringer, P. Chellan, B. Therrien, N. Shunmoogam-
Gounden, D. T. Hendricks, G. S. Smith, Polyhedron 2009, 28,
2839–2846.
595 nm on a BioTek microplate reader.
17] Z. Iakovidou, E. Mioglou, D. Mourelatos, A. Kotsis, M. A.
Demertzis, A. Papagoegiou, J. R. Miller, D. Kovala-Demertzi,
Anticancer Drugs 2001, 12, 65–70.
18] A. Garoufis, S. K. Hadjikakou, N. Hadjiliadis, Metall-
otherapeutic Drugs and Metal-based Diagnostic Agents: The
Use of Metals in Medicine (Eds.: M. Gielen, E. R. T. Tiekink),
John Wiley & Sons Ltd, 2005, chapter 21, p. 399, and refer-
ences cited therein.
Western Blot Analysis: Cells were harvested in 60 µL of radioim-
muno-precipitation assay buffer [150 mmol/L NaCl, 1% Triton X-
100, 0.1% SDS, 25 mmol/L Tris-HCl (pH 7.5), 1% sodium deoxy-
cholate, 1 mmol/L Na VO , 20 µg/mL pepstatin, 1 mmol/L phenyl-
3
4
methylsulfonyl fluoride] with protease inhibitor (Complete tablets,
Roche), sonicated for 10 s with a probe sonicator (Heat System-
Ultrasonics) and centrifuged for 15 min at 13,000 g. The protein
concentration of the lysates was determined using the BCA Protein
Assay Kit (Pierce). Equal amounts of protein was electrophoresed
on 10% SDS polyacrylamide gel at a constant current of 15 mA
and electrophoretically transferred to a nitrocellulose membrane
[
19] D. Kovala-Demertzi, M. A. Demertzis, J. R. Miller, C. Papado-
poulou, C. Dodorou, G. Filousis, J. Inorg. Biochem. 2001, 86,
555–563.
[
20] M. Das, S. E. Livingstone, Br. J. Cancer 1978, 37, 463–466.
[21]
A. G. Quiroga, J. M. Perez, I. Lopez-Solera, J. R. Masaguer, A.
Luque, P. Roman, A. Edwards, C. Alonso, C. Navarro-Ran-
ninger, J. Med. Chem. 1998, 41, 1399–1408.
(Hybond-ECL; Amersham Pharmacia Biotech UK) at 100 V for
1
h. Membranes were incubated for 1 h with 5% fat-free dry milk
in TBS with 0.1% Tween 20 to block nonspecific binding sites and
then incubated with 1:1000 dilution of rabbit polyclonal primary
antibody to poly (ADP ribose) polymerase (Santa Cruz Biotech-
nology) at 4 °C overnight. The immunoreactivity was detected by
using peroxidase-conjugated antirabbit secondary antibody and
visualized by enhanced chemiluminescence (SuperSignal West Pico
Chemiluminescent Substrate; Pierce). The blots were stripped be-
fore reprobing with antibody to β-tubulin (Santa Cruz Biotechnol-
ogy).
[22] A. G. Quiroga, J. M. Perez, C. Alonso, C. Navarro-Ranninger,
Appl. Organomet. Chem. 1998, 12, 809–813.
23] A. G. Quiroga, J. M. Perez, E. I. Montero, C. Alonso, C. Nav-
arro-Ranninger, J. Inorg. Biochem. 1999, 75, 293–301.
[
[
24] D. Kovala-Demertzi, A. Alexandratos, A. Papageogiou, P. N.
Yadav, P. Dalezis, M. A. Demertzis, Polyhedron 2008, 27, 2731–
2738.
[
[
[
[
25] S. Padhye, Z. Afrasiabi, E. Sinn, J. Fok, K. Mehta, N. Rath,
Inorg. Chem. 2005, 44, 1154–1156.
26] J. Patole, S. Padhye, M. S. Moodbidri, N. Shirsat, Eur. J. Med.
Chem. 2005, 40, 1052–1055.
27] A. G. Quiroga, L. Cubo, P. J. S. Miguel, V. Moneo, A. Carnero,
C. Navarro-Ranninger, Eur. J. Inorg. Chem. 2008, 1183–1187.
28] D. Kovala-Demertzi, P. N. Yadav, M. A. Demertzis, M. Coluc-
cia, J. Inorg. Biochem. 2000, 78, 347–354.
Acknowledgments
We gratefully thank the University of Cape Town, the National
Research Foundation (NRF), the Medical Research Council
[29] J. P. Scovill, D. L. Klayman, D. G. Franchino, J. Med. Chem.
1982, 25, 1261–1265.
(MRC) of South Africa and the Cancer Association of South
[30] I. D. Kostas, F. J. Andreadaki, D. Kovala-Demertzi, C.
Africa (CANSA) for financial support. AngloPlatinum Corpora-
tion and Johnson Matthey is acknowledged for the kind donation
of palladium salts.
Prentjas, M. A. Demertzis, Tetrahedron Lett. 2005, 46, 1967–
1970.
[31] A. P. Kumar, Anal. Lett. 2008, 41, 1022–1037.
[32] I. Yilmaz, Heteroat. Chem. 2003, 14, 617–621.
[
1] E. W. Ainscough, A. M. Brodie, W. A. Denny, G. J. Finlay, J. D.
[33] J. Albert, J. Granell, J. Sales, M. Fon-Bardia, X. Solans, Orga-
nometallics 1995, 14, 1393–1404.
Ranford, J. Inorg. Biochem. 1998, 70, 175–185.
Eur. J. Inorg. Chem. 2010, 3520–3528
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
3527